Comparison of the Efficacy between Pemetrexed plus Platinum and Non-Pemetrexed plus Platinum as First-Line Treatment in Patients with Wild-Type Epidermal Growth Factor Receptor Nonsquamous Non-Small Cell Lung Cancer: A Retrospective Analysis

By  

Chemotherapy, Vol. 61, Iss. 1, 2015-0 ,pp. : 41-50

Karger

Access to resources Recommend Favorite

The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation

By Liu Tu-Chen   Hsieh Ming-Ju   Liu Ming-Che   Chiang Whei-Ling   Tsao Thomas Chang-Yao   Yang Shun-Fa  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 763-763

MDPI

Access to resources Recommend Favorite

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer

By Chang Shih-Chieh   Chang Cheng-Yu   Shih Jin-Yuan  

Cancers, Vol. 3, Iss. 2, 2011-06 ,pp. : 2667-2678

MDPI

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis

By Chiramel Jaseela   Backen Alison C.   Pihlak Rille   Lamarca Angela   Frizziero Melissa   Tariq Noor-ul-Ain   Hubner Richard A.   Valle Juan W.   Amir Eitan   McNamara Mairéad G.  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-04 ,pp. : 909-909

MDPI

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 108-114

Karger

Access to resources Recommend Favorite